Glucuronolactone (D-Glucurono-γ-Lactone)

Endogenous metabolite; produced from glucose
Evidence Level
Preliminary
3 Clinical Trials
5 Documented Benefits
1/5 Evidence Score

Glucuronolactone is a compound naturally produced by the body and found in connective tissue, most familiar as a common ingredient in energy drinks alongside caffeine and taurine. It is marketed for energy, reduced fatigue, and detoxification, though strong independent evidence for these specific benefits is limited, and much of an energy drink's effect comes from its caffeine and sugar. It is typically consumed within energy-drink formulas rather than as a standalone supplement. At the amounts in energy drinks it is generally considered safe, and the body makes it naturally; long-term high-dose data is limited.

Studied Dose Red Bull: 600 mg per 250 mL. EU SCF safe up to 250 mg/kg/day. Isolated supplements: 200-2,000 mg/day.
Active Compound D-Glucurono-γ-lactone — a naturally occurring metabolite formed from glucose oxidation; also found in connective tissue and plant gum-resins.

Benefits

Component of energy drink combinations

One study examined Red Bull (containing taurine 1 g, caffeine 80 mg, glucuronolactone 600 mg, glucose 5.25 g) across multiple substudies in volunteers, finding improved choice reaction time, concentration, immediate-recall memory, and aerobic/anaerobic exercise performance versus control drinks. Critical caveat: glucuronolactone-specific effects cannot be isolated from caffeine, taurine, glucose, and B vitamins; effects are predominantly attributable to caffeine.

Driver alertness in combination energy drink

One study gave 500 mL of a Red Bull-style drink to sleepy drivers in a simulator and found improved lane-keeping and reaction time versus control without active ingredients. Same critical caveat — combination effects, not glucuronolactone-specific. The active ingredient driving alertness is overwhelmingly caffeine.

Detoxification cofactor (theoretical)

Glucuronolactone is a precursor in the body's natural glucuronidation pathway — Phase II conjugation system that converts xenobiotics into water-soluble glucuronides for excretion. Theoretical mechanism for 'detox' marketing claims. Critical caveat: body produces glucuronolactone endogenously in adequate amounts; supplementation has not been shown to enhance detoxification rates in clinical studies.

Connective tissue support (theoretical)

Glucuronolactone metabolism contributes to glycosaminoglycan synthesis (chondroitin, hyaluronic acid). Theoretical role in connective tissue support. No clinical evidence for joint health benefits from supplementation.

Possible mood/cognitive effects (very limited)

Some animal studies suggest glucuronolactone has mild independent stimulating effects beyond caffeine/taurine combinations. Effects are unclear; one frequently cited study reported mood improvements but its methodology is questionable by modern standards. There are no rigorous modern human RCTs of isolated glucuronolactone.

Mechanism of action

1

Glucuronidation pathway substrate

Glucuronolactone is a precursor in glucuronic acid production and Phase II glucuronidation — major detoxification pathway for drugs, hormones, bilirubin, and xenobiotics. UDP-glucuronosyltransferases (UGTs) conjugate substrates with glucuronic acid for biliary or renal excretion. Mechanism for theoretical 'detox' role but body produces sufficient endogenously.

2

Glycosaminoglycan precursor

Glucuronic acid (from glucuronolactone) is a building block of glycosaminoglycans — chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin. Mechanism for theoretical connective tissue support but no clinical supplementation evidence.

3

Possible mild stimulant effect (mechanism unclear)

Some animal evidence and Red Bull combination trials suggest glucuronolactone has independent mild stimulant or mood effects. Mechanism not clearly established — possibly via central nervous system effects on dopaminergic/adrenergic systems. Speculative without rigorous human pharmacological characterization.

4

Endogenous production sufficient

Body produces glucuronolactone from glucose oxidation in normal physiological amounts. Dietary supplementation rarely provides clinically meaningful additional substrate for any of the proposed mechanisms. The pharmacological logic for supplementation is therefore questionable independent of efficacy data.

Clinical trials

1
Red Bull Energy Drink Effects (Pivotal Combo)

Three studies compilation (Alford C, Cox H, Amino Acids 21(2):139-150, doi:10.1007/s007260170021).

36 volunteers across 3 studies. Standard 250 mL Red Bull (containing taurine 1g + caffeine 80mg + glucuronolactone 600mg + glucose 5.25g + B vitamins) vs control drinks. Tests: psychomotor performance (reaction time, concentration, memory), subjective alertness, physical endurance (cycle ergometer aerobic and anaerobic).

Red Bull significantly improved (P<0.05): aerobic endurance (65-75% max HR maintenance), anaerobic performance (max speed maintenance), choice reaction time, concentration (number cancellation), memory (immediate recall), subjective alertness. Authors interpreted as combination effect of ingredients. Critical limitation: cannot isolate glucuronolactone effect — caffeine is primary contributor; glucuronolactone-specific contribution unknown.

2
Energy Drink in Sleepy Drivers

Driver simulator clinical trial (Horne JA, Reyner LA 2001, Amino Acids 20(1):83-89, doi:10.1007/s007260170068).

11 sleepy participants in interactive real-car driving simulator. 500 mL glucose-based 'energy drink' (containing caffeine, taurine, glucuronolactone) vs control drink without active ingredients. Lane drifting and reaction time measured for 2 hours post-treatment.

Energy drink significantly improved both indices, particularly during the first hour. Effect attributed to combined caffeine + taurine + glucuronolactone but caffeine recognized as primary contributor. Same combination-product limitation prevents glucuronolactone-specific attribution. Established energy drinks (and presumably their caffeine content) reduce sleep-related driving impairment.

3
Cardio/Cerebrovascular Responses to Red Bull

Cardiovascular clinical trial (Grasser EK, Yepuri G, Dulloo AG, Montani JP 2014, Eur J Nutr 53(7):1561-1571, doi:10.1007/s00394-014-0661-8).

25 young non-obese healthy subjects in randomized crossover. Beat-to-beat BP, impedance cardiography, transcranial Doppler, microvascular endothelial function tests measured 2 hours post 355 mL Red Bull (caffeine 114mg + taurine 1,420mg + glucuronolactone 84.2mg + sucrose/glucose 39.1g) vs water.

Red Bull produced 'negative hemodynamic profile' in young healthy humans not explained by impairment in endothelial function. BP and HR effects observed. Authors recommended further experiments to tease out distinct components — acknowledging the impossibility of attributing effects to glucuronolactone vs caffeine/taurine/sugars in combination products.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at typical doses; EU Scientific Committee on Food assessed safe up to 250 mg/kg/day.
Mild GI upset at high doses.
When in energy drinks: cardiovascular effects (BP, HR) primarily from caffeine.
Pregnancy/lactation: limited isolated data; energy drinks generally not recommended.
Allergic reactions: rare.
No significant adverse effects associated with isolated glucuronolactone supplementation.

Important Drug interactions

Generally no clinically significant interactions documented.
When in energy drinks: caffeine contributes to most interaction concerns (CYP1A2 substrates, etc.).
Compatible with most medications.
Phase II metabolism cofactors: theoretical relevance to drugs metabolized via glucuronidation but clinical importance unclear.
No specific drug-glucuronolactone interaction warnings in clinical practice.

Frequently asked questions about Glucuronolactone (D-Glucurono-γ-Lactone)

What is glucuronolactone used for?

Glucuronolactone is a compound naturally produced by the body and found in connective tissue, commonly added to energy drinks alongside caffeine and taurine. It is marketed for energy, detoxification, and reduced fatigue.

What does glucuronolactone do in energy drinks?

It is included for proposed effects on energy, mental performance, and detoxification, though strong independent evidence for these benefits is limited. Much of an energy drink's effect comes from caffeine and sugar rather than glucuronolactone.

How much glucuronolactone should I take?

It is typically consumed within energy-drink formulas at the amounts those provide; standalone supplements follow product labeling. There is no established therapeutic dose.

Is glucuronolactone safe?

At the amounts in energy drinks it is generally considered safe, and the body makes it naturally. Long-term high-dose data is limited, and the main cautions with energy drinks relate to their caffeine and sugar rather than glucuronolactone itself.

What is Glucuronolactone?

Glucuronolactone is a compound naturally produced by the body and found in connective tissue, most familiar as a common ingredient in energy drinks alongside caffeine and taurine.

What is the recommended dosage of Glucuronolactone?

The clinically studied dose is Red Bull: 600 mg per 250 mL. EU SCF safe up to 250 mg/kg/day. Isolated supplements: 200-2,000 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Glucuronolactone safe, and does it have side effects?

For most healthy adults, Glucuronolactone is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at typical doses; EU Scientific Committee on Food assessed safe up to 250 mg/kg/day. Mild GI upset at high doses. It may also interact with some medications. Glucuronolactone is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Glucuronolactone interact with any medications?

Possible interactions include: Generally no clinically significant interactions documented. When in energy drinks: caffeine contributes to most interaction concerns (CYP1A2 substrates, etc.). If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Glucuronolactone?

NutraSmarts rates the evidence for Glucuronolactone as Preliminary (1 out of 5). It is backed by 3 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Seidl R, Peyrl A, Nicham R, Hauser E A taurine and caffeine-containing drink stimulates cognitive performance and well-being Amino Acids. 2000;19(3-4):635-42. doi:10.1007/s007260070013.PubMedUsed to support: Double-blind placebo-controlled study (n=10 graduate students) showing that a Red Bull-type drink containing caffeine, taurine, and glucuronolactone maintained P300 latency and reaction time vs placebo deterioration during late-night testing, and preserved well-being scores; relevant to 'Component of energy drink combinations' and 'Driver alertness in combination energy drink' benefits. Glucuronolactone was one of three active ingredients; isolated contribution not separable.
  2. McLellan TM, Lieberman HR Do energy drinks contain active components other than caffeine? Nutrition Reviews. 2012;70(12):730-44. doi:10.1111/j.1753-4887.2012.00525.x.PubMedUsed to support: Systematic review evaluating evidence for energy drink ingredients beyond caffeine, including taurine, B vitamins, and glucuronolactone; concludes that most cognitive/performance benefits of energy drinks are attributable to caffeine, with limited independent evidence for glucuronolactone; supports honest framing of 'Possible mood/cognitive effects (very limited)' and 'Detoxification cofactor (theoretical)' as speculative without isolated clinical evidence.